Antibody-drug Conjugate Information

General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0WSLPF
ADC Name
Anti-FucGM1 mAb-IIIb-01
Synonyms
Anti-FucGM1-mAb-IIIb-01
   Click to Show/Hide
Organization
Bristol Myers Squibb Co.
Drug Status
Investigative
Indication
In total 1 Indication(s)
Small cell lung cancer
Investigative
.
Drug-to-Antibody Ratio
2
Antibody Name
Anti-FucGM1 mAb
  Antibody Info 
Antigen Name
Fucosylated monosialotetrahexosylganglioside (FucGM1)
  Antigen Info 
Payload Name
Undisclosed
Linker Name
Anti-FucGM1 mAb linker
Conjugate Type
Random conjugation through reduced inter-chain cysteines.
General Information of The Activity Data Related to This ADC
Revealed Based on the Cell Line Data
Click To Hide/Show 3 Activity Data Related to This Level
Standard Type Value Units Cell Line Disease Model
Half Maximal Effective Concentration (EC50) 
0.3
nM
CVCL_1178
Small cell lung carcinoma
Half Maximal Effective Concentration (EC50) 
0.5
nM
CVCL_1501
Lung small cell carcinoma
Half Maximal Effective Concentration (EC50) 
> 100
nM
CVCL_1603
Gastric tubular adenocarcinoma
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
Click To Hide/Show 3 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Effective Concentration (EC50) 0.30 nM Positive FucGM1 expression (FucGM1+++/++)
Method Description
The MTS cell proliferation assay was performed as follows: CellTiter 96 Aqueous Non-Radioactive Cell proliferation Kit is used to determine the number of viable cells in cell proliferation assay. Tumor cells are plated at certain seeding densities in sterile 384-well black clear bottom Matrix plates at 40 uL per well and incubated overnight at 37°C in 5% CO2 before assaying.

   Click to Show/Hide
In Vitro Model Small cell lung carcinoma DMS-79 cells CVCL_1178
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Effective Concentration (EC50) 0.50 nM Positive FucGM1 expression (FucGM1+++/++)
Method Description
The MTS cell proliferation assay was performed as follows: CellTiter 96 Aqueous Non-Radioactive Cell proliferation Kit is used to determine the number of viable cells in cell proliferation assay. Tumor cells are plated at certain seeding densities in sterile 384-well black clear bottom Matrix plates at 40 uL per well and incubated overnight at 37°C in 5% CO2 before assaying.

   Click to Show/Hide
In Vitro Model Lung small cell carcinoma NCI-H187 cells CVCL_1501
Experiment 3 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Effective Concentration (EC50) > 100.00 nM Negative FucGM1 expression (FucGM1-)
Method Description
The MTS cell proliferation assay was performed as follows: CellTiter 96 Aqueous Non-Radioactive Cell proliferation Kit is used to determine the number of viable cells in cell proliferation assay. Tumor cells are plated at certain seeding densities in sterile 384-well black clear bottom Matrix plates at 40 uL per well and incubated overnight at 37°C in 5% CO2 before assaying.

   Click to Show/Hide
In Vitro Model Gastric tubular adenocarcinoma NCI-N87 cells CVCL_1603
References
Ref 1 Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using.